Dorsey Wright & Associates

Position in NVS — Novartis AG

CIK 1376772 PASADENA, CA

Position in NVS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,815,601

-$668,725 QoQ

Shares Held

11,585

-28.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#456

of 1,603 holders

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dorsey Wright & Associates holds $9,326,220 across 5 Drug Manufacturers - General names. NVS ranks #2 (19.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	19,191	$4,873,938
2	NVS	Novartis AG This page	11,585	$1,815,601
3	GSK	GSK plc	32,575	$1,707,581
4	LLY	ELI LILLY & Co	468	$561,333
5	MRK	Merck & Co., Inc.	2,862	$367,767

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,815,601	11,585	-28.8%	Shares	Sole	2026-08-06
2026-03-31	$2,484,326	16,264	-13.1%	Shares	Sole	2026-05-06
2024-12-31	$1,820,475	18,708	-9.3%	Shares	Sole	2025-02-12
2024-09-30	$2,371,482	20,618	-38.1%	Shares	Sole	2024-11-15
2020-09-30	$2,894,637	33,287	+1.4%	Shares	Sole	2020-10-28
2020-06-30	$2,866,411	32,819	-7.5%	Shares	Sole	2020-07-23
2020-03-31	$2,924,006	35,464	—	Shares	Sole	2020-04-20
No filing history on record for this holder in this stock.